Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
BIOCELECT NEW ZEALAND LIMITED,SARS-CoV-2 rS (Omicron XBB.1.5),prevention of COVID-19,SARS-CoV-2 rS (Omicron XBB.1.5) (NUVAXOVID XBB.1.5),Recommended for decline,Community and Hospital,
